Ontology highlight
ABSTRACT:
SUBMITTER: Bishton MJ
PROVIDER: S-EPMC9928637 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
Bishton Mark J MJ Salles Gilles G Golfier Camille C Knauf Wolfgang W Bocchia Monica M Turner Deborah D Slama Borhane B Harchowal Jatinder J Marshall Scott S Bosi Alberto A Lleonart Juan José Bargay JJB Welslau Manfred M Kim SooKyoung S Lee Young N YN Zinzani Pier L PL Laribi Kamel K
EJHaem 20221106 1
The rituximab biosimilar CT-P10 is approved for the treatment of non-Hodgkin lymphoma. Previous studies have demonstrated clinical similarity between CT-P10 and reference rituximab. However, real-world data relating to treatment in patients with DLBCL with rituximab biosimilars are limited. This study collected real-world data relating to the effectiveness and safety of CT-P10 treatment from the medical records of 389 patients with DLBCL (24 centers, five European countries). For the primary out ...[more]